The association of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: A pooled analysis of individual patient data from first-line clinical trials.

被引：0
|
作者：
Bolt, Toki Anna
Pauligk, Claudia
Werner, Dominique
Mayer, Frank
Hofheinz, Ralf Dieter
Homann, Nils
Luley, Kim
Al-Batran, Salah-Eddin
机构：
[1] UCT Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany
[2] Univ Hosp, Med Ctr 2, Tubingen, Germany
[3] Univ Med Ctr Mannheim, Dept Hematol & Med Oncol, Mannheim, Germany
[4] Klinikum Wolfsburg, Wolfsburg, Germany
[5] Univ Klinikum Lubeck, Lubeck, Germany
[6] Krankenhaus NW Frankfurt, Frankfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4095
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The association of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: A pooled analysis of individual patient data from first-line clinical trials
    Bolt, T. A.
    Pauligk, C.
    Werner, D.
    Mayer, F.
    Hofheinz, R. D.
    Homann, N.
    Luley, K.
    Al-Batran, S. -E
    ONKOLOGIE, 2013, 36 : 122 - 123
  • [2] Impact of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: Landmark analysis of 10 year data from first-line clinical trials
    Bolt, T. A.
    Pauligk, C.
    Werner, D.
    Mayer, F.
    Hofheinz, R.
    Nils, H.
    Luley, K.
    Schmalenberg, H.
    Egger, M.
    Al-Batran, S-E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 52 - 52
  • [3] Impact of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: Landmark analysis of 10-year data from first-line clinical trials
    Bolt, Toki Anna
    Pauligk, Claudia
    Werner, Dominique
    Hofheinz, Ralf Dieter
    Mayer, Frank
    Luley, Kim Barbara
    Homann, Nils
    Schmalenberg, Harald
    Egger, Matthias
    Al-Batran, Salah-Eddin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [4] Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials
    Arai, Hiroyuki
    Takeuchi, Madoka
    Ichikawa, Wataru
    Shitara, Kohei
    Sunakawa, Yu
    Oba, Koji
    Koizumi, Wasaburo
    Sakata, Yuh
    Furukawa, Hiroshi
    Yamada, Yasuhide
    Takeuchi, Masahiro
    Fujii, Masashi
    CANCER MEDICINE, 2024, 13 (01):
  • [5] Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomized controlled trials.
    Ronellenfitsch, Ulrich
    Jensen, Katrin
    Seide, Svenja
    Kieser, Meinhard
    Schwarzbach, Matthias
    Slanger, Tracy E.
    Burmeister, Bryan
    Kelsen, David Paul
    Niedzwiecki, Donna
    Piessen, Guillaume
    Schuhmacher, Christoph
    Urba, Susan
    Van de Velde, Cornelis
    Ychou, Marc
    Hofheinz, Ralf Dieter
    Lorenzen, Sylvie
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database
    Renfro, Lindsay A.
    Loupakis, Fotios
    Adams, Richard A.
    Seymour, Matthew T.
    Heinemann, Volker
    Schmoll, Hans-Joachim
    Douillard, Jean-Yves
    Hurwitz, Herbert
    Fuchs, Charles S.
    Diaz-Rubio, Eduardo
    Porschen, Rainer
    Tournigand, Christophe
    Chibaudel, Benoist
    Falcone, Alfredo
    Tebbutt, Niall C.
    Punt, Cornelis J. A.
    Hecht, J. Randolph
    Bokemeyer, Carsten
    Van Cutsem, Eric
    Goldberg, Richard M.
    Saltz, Leonard B.
    de Gramont, Aimery
    Sargent, Daniel J.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) : 144 - +
  • [7] Progression-free survival as surrogate endpoint of overall survival in patients with advanced/recurrent gastric cancer: Individual patient data analysis on 4,102 patients from 20 randomized trials.
    Shitara, K.
    Burzykowski, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Objective response of first-line chemotherapy in patients with metastatic triple-negative breast cancer confers a better overall survival.
    Li, Ting
    Zhang, Jian
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Sheng
    Wang, Leiping
    Cao, Jun
    Tao, Zhonghua
    Xie, Jie
    Zhang, JinFeng
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
    Blum, Joanne L.
    Barrios, Carlos H.
    Feldman, Nancy
    Verma, Sunil
    McKenna, Edward F.
    Lee, Luen F.
    Scotto, Nana
    Gralow, Julie
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 777 - 788
  • [10] Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
    Joanne L. Blum
    Carlos H. Barrios
    Nancy Feldman
    Sunil Verma
    Edward F. McKenna
    Luen F. Lee
    Nana Scotto
    Julie Gralow
    Breast Cancer Research and Treatment, 2012, 136 : 777 - 788
12345